165 filings
8-K
TCON
TRACON Pharmaceuticals Inc
14 May 24
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:05pm
8-K
TCON
TRACON Pharmaceuticals Inc
13 May 24
Departure of Directors or Certain Officers
8:00am
8-K
TCON
TRACON Pharmaceuticals Inc
12 Apr 24
Results of Operations and Financial Condition
4:43pm
8-K
TCON
TRACON Pharmaceuticals Inc
10 Apr 24
Other Events
8:05am
8-K
TCON
TRACON Pharmaceuticals Inc
8 Apr 24
TRACON Pharmaceuticals Announces Reverse Stock Split
9:15am
8-K
uh1rer3
3 Apr 24
ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024
8:05am
8-K
db9s4wni7a 7xzr
5 Mar 24
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
4:08pm
8-K
1dnwafgw 14weoo
19 Dec 23
Other Events
5:00pm
8-K
ytd4odryzc9ekfojb
8 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
towc7hboocr 17a
20 Nov 23
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment
8:05am
8-K
esfce6d
9 Nov 23
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
nqwdat
6 Oct 23
Departure of Directors or Certain Officers
5:00pm
8-K
1wrfhiqnqzcwqf
18 Sep 23
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
8:10am
8-K
n3o7t04rd5u38
7 Sep 23
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
nv89tg31mnc
14 Aug 23
TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:12pm
8-K
54ou099e t7btg2
11 Jul 23
TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma
8:08am
8-K
zae6dt
20 Jun 23
Single Agent Envafolimab ORR Exceeded Futility Rule that will be Applied at the Interim Efficacy Analysis Expected in Q3
8:08am
8-K
q7pxu59kxcajtmtvk6
15 Jun 23
Other Events
8:08am
8-K
6nt5ut75xbu
9 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
0rv2j0aq64x3ij
2 Jun 23
Unregistered Sales of Equity Securities
5:01pm